Discrepancies in Composition and Biological Effects of Different Formulations of Chondroitin Sulfate

Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography–electrospray ionization–tandem mass spectrometry

(2014) Harumi Osago et al.   ANALYTICAL BIOCHEMISTRY

Osteoarthritis research priorities: a report from a EULAR ad hoc expert committee

(2014) Philip G Conaghan et al.   ANNALS OF THE RHEUMATIC DISEASES

Absorption, distribution and mechanism of action of SYSADOAS

(2014) Patrick du Souich   PHARMACOLOGY & THERAPEUTICS

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

(2014) Olivier Bruyère et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: A systematic review and meta-analysis

(2013) Raveendhara R. Bannuru et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Total Knee Replacement as a Knee Osteoarthritis Outcome

(2013) Jean-Pierre Raynauld et al.   Cartilage

Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro

(2013) M. D. Cantley et al.   INFLAMMOPHARMACOLOGY

Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what’s the evidence?

(2012) M. Hochberg et al.   CURRENT MEDICAL RESEARCH AND OPINION

Interpretation of Metaanalyses: Pitfalls Should Be More Widely Recognized

(2012) Y. E. HENROTIN   JOURNAL OF RHEUMATOLOGY

Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI

(2011) L. M. Wildi et al.   ANNALS OF THE RHEUMATIC DISEASES

Pharmacoproteomic Study of Three Different Chondroitin Sulfate Compounds on Intracellular and Extracellular Human Chondrocyte Proteomes

(2011) Valentina Calamia et al.   MOLECULAR & CELLULAR PROTEOMICS

OARSI-FDA initiative: defining the disease state of osteoarthritis

(2011) N.E. Lane et al.   OSTEOARTHRITIS AND CARTILAGE

The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review

(2011) D. Pereira et al.   OSTEOARTHRITIS AND CARTILAGE

Effect of chondroitin sulfate-E on the osteoclastic differentiation of RAW264 cells

(2010) Tatsuya MIYAZAKI et al.   DENTAL MATERIALS JOURNAL

Quality of different chondroitin sulfate preparations in relation to their therapeutic activity

(2010) Nicola Volpi   JOURNAL OF PHARMACY AND PHARMACOLOGY

Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique

(2010) K.D. Rainsford   JOURNAL OF PHARMACY AND PHARMACOLOGY

Variable Effects of 3 Different Chondroitin Sulfate Compounds on Human Osteoarthritic Cartilage/Chondrocytes: Relevance of Purity and Production Process

(2010) S. K. TAT et al.   JOURNAL OF RHEUMATOLOGY

Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration

(2010) M.C. Hochberg   OSTEOARTHRITIS AND CARTILAGE

Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis

(2009) Young Ho Lee et al.   RHEUMATOLOGY INTERNATIONAL

Chondroitin sulphate: A complex molecule with potential impacts on a wide range of biological systems

(2008) Robert M. Lauder   COMPLEMENTARY THERAPIES IN MEDICINE

The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate

(2008) Marc C. Hochberg et al.   CURRENT MEDICAL RESEARCH AND OPINION

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

(2008) Marco Guerrini et al.   NATURE BIOTECHNOLOGY

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

(2008) Takashi Kei Kishimoto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations

(2007) Christina J. Malavaki et al.   ANALYTICAL BIOCHEMISTRY

Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues

(2007) J Monfort et al.   ANNALS OF THE RHEUMATIC DISEASES